Market Recap Check: I-Mab ADR (IMAB)’s Negative Finish at 0.90, Up/Down -0.01

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

The price of I-Mab ADR (NASDAQ: IMAB) closed at $0.90 in the last session, down -0.01% from day before closing price of $0.90. In other words, the price has decreased by -$0.01 from its previous closing price. On the day, 0.65 million shares were traded.

Ratios:

We take a closer look at IMAB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 16.50 and its Current Ratio is at 16.50. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Siebert Williams Shank on December 09, 2021, initiated with a Buy rating and assigned the stock a target price of $96.

On March 15, 2021, Needham started tracking the stock assigning a Buy rating and target price of $75.Needham initiated its Buy rating on March 15, 2021, with a $75 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 26 ’24 when KANNAN RAJ bought 50,000 shares for $1.39 per share.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 63.08 while its Price-to-Book (P/B) ratio in mrq is 0.29.

Stock Price History:

Over the past 52 weeks, IMAB has reached a high of $2.00, while it has fallen to a 52-week low of $0.84. The 50-Day Moving Average of the stock is -8.14%, while the 200-Day Moving Average is calculated to be -26.80%.

Shares Statistics:

A total of 77.02M shares are outstanding, with a floating share count of 76.81M. Insiders hold about 0.27% of the company’s shares, while institutions hold 15.68% stake in the company.

Most Popular